Evidence Question

Does Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) reduce Hypoglycemia events?

Related to: Hypoglycemia

Short answer

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) appears to reduce Hypoglycemia events.

How the evidence connects

Each connection shows the published evidence classification for that intervention and outcome relationship.

Intervention

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)

Intervention

Emerging

Unclear

1 study · 1 RCT

Outcome

Hypoglycemia events

Outcome

Intervention

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)

Evidence signature

Emerging

Not available

Unclear

1 study · 1 RCT

Outcome

Hypoglycemia events

Why do we say this?

The directional finding currently comes from one supporting study, so the evidence base remains limited and the finding should be interpreted cautiously.

Explore the evidence

Open in Evidence Explorer View Hypoglycemia

Does Hybrid closed-loop system affect Hypoglycemia events?
What does the evidence report about hypoglycemia events with hybrid closed loop system?
Does Insulin therapy reduce Hypoglycemia events?

Short answer

How the evidence connects

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)

Hypoglycemia events

Why do we say this?

Explore the evidence

Related questions